Galectin-9-ligand axis: an emerging therapeutic target for multiple myeloma Review

Shil, Rajib K, Mohammed, Norhan BB, Dimitroff, Charles J. (2024). Galectin-9-ligand axis: an emerging therapeutic target for multiple myeloma . Frontiers in Immunology, 15 10.3389/fimmu.2024.1469794

Open Access International Collaboration

cited authors

  • Shil, Rajib K; Mohammed, Norhan BB; Dimitroff, Charles J

sustainable development goals

authors

publication date

  • September 25, 2024

published in

keywords

  • BONE-DISEASE
  • CARBOHYDRATE-RECOGNITION DOMAINS
  • DENDRITIC CELLS
  • DOWN-REGULATION
  • GLYCAN INTERACTIONS
  • Immunology
  • Life Sciences & Biomedicine
  • PLASMA-CELLS
  • PROGNOSTIC-SIGNIFICANCE
  • RACIAL DISPARITIES
  • REGULATORY T-CELLS
  • SUPPRESSOR-CELLS
  • Science & Technology
  • galectin-9
  • galectins
  • multiple myeloma
  • therapy
  • tumor microenvironment

Digital Object Identifier (DOI)

volume

  • 15